Patents by Inventor Sandra Sermone

Sandra Sermone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ketamine for treatment of ADNP syndrome and sensory processing deficits
    Patent number: 11571396
    Abstract: A method of treating sensory processing disorder, autism spectrum disorder, and/or ADNP syndrome comprising the administration of low doses of ketamine and/or low doses of ketamine and NAP.
    Type: Grant
    Filed: March 23, 2020
    Date of Patent: February 7, 2023
    Inventors: Sandra Sermone, Matthew Davis
  • KETAMINE AND KETAMINE/NAP FOR TREATMENT OF ADNP SYNDROME AND RELATED NEUROLOGICAL CONDITIONS
    Publication number: 20220257536
    Abstract: The invention is directed to a method of increasing the expression of Activity-Dependent Neuroprotector Protein (ADNP) in at least one mammalian cell showing insufficient ADNP expression levels, comprising administering to the at least one mammalian ceil an effective amount of ketamine or a combination of ketamine and ADNP-Derived Neuroprotective Peptide (NAP).
    Type: Application
    Filed: June 4, 2020
    Publication date: August 18, 2022
    Inventors: Sandra SERMONE, Matthew Christopher DAVIS
  • KETAMINE FOR TREATMENT OF ADNP SYNDROME AND SENSORY PROCESSING DEFICITS
    Publication number: 20200297662
    Abstract: A method of treating sensory processing disorder, autism spectrum disorder, and/or ADNP syndrome comprising the administration of low doses of ketamine and/or low doses of ketamine and NAP.
    Type: Application
    Filed: March 23, 2020
    Publication date: September 24, 2020
    Inventors: Sandra Sermone, Matthew Davis